|
|
Mental Disease Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Mental Disease Therapeutic, including, but not limited to market trend on Therapeutic of: Antidepressant; Psychiatric Disorder; Insomnia; Neurodegenerative; Antianxiety; Antipsychotics; Alzheimer; Psychiatry; PTSD.
We offer market research, industry forecasts, and business analysis in the Mental Disease Therapeutic as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Alzheimer disease - new drugs, markets and companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| Alzheimer' s disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechan ... |
| Attention-Deficit Hyperactivity Disorder Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Driven primarily by continued uptake of Shire' s market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. ... |
| The Psychiatric Disease Pipeline: A Strategic Review |
|
| Table of Contents Published: 2009/07 Published by: Decision Resources, Inc. |
| Numbers tell the story in psychiatric disease drug development: almost 300 recognized indications, 28% 12-month prevalence that yields large patient populations, strong 7.5% annual sales growth in recent years, sustained franchise sales, tolerance for use ... |
| Nicotine Dependence Market Forecast |
|
| Table of Contents Published: 2009/04 Published by: Datamonitor |
| With a considerable patient population and continued government focus on lowering national smoking rates, the nicotine dependence market represents a lucrative opportunity for pharmaceutical companies. ... |
| Chinese Markets for Mental Illness Drugs |
|
| Table of Contents Published: 2009/02 Published by: Asia Market Information & Development Co. |
| China' s demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, ... |
| Alzheimer's Disease Biomarkers, 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This report gives a comprehensive and up-to-date review of Alzheimer' s disease biomarkers. Recent years have seen significant advances in this field. Whilst considerable effort has focused on AƒÀ and tau related markers, a substantial number of other mol ... |
| U.S. Markets for Addiction & Substance Abuse Treatment |
|
| Table of Contents Published: 2009/01 Published by: BCC Research |
| The study is designed to be a comprehensive business tool that provides an in-depth look at the world of substance abuse treatments and diagnostics. The geographic scope of the report is the United States. The report identifies the different drugs of addi ... |
| Sleep Disorders - US - November 2008 |
|
| Table of Contents Published: 2008/11 Published by: Mintel International Group Ltd, |
| The U.S. Sleep Aid market has doubled between 2002 and 2007. OTC and homeopathic segments, which are considerably smaller, are likely to continue growing, fueled by fears surrounding side effects and dependencies that may result from prescription solution ... |
| The Global Anti-Addiction Market, 2008-2023 |
|
| Table of Contents Published: 2008/11 Published by: Visiongain |
| The global addiction market is significantly undervalued. The world' s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents? The brand new report, The Global Anti-Addiction Market, 2008-2023, pro ... |
| Substance Abuse Alcoholism |
|
| Table of Contents Published: 2008/03 Published by: Life Science Analytics |
| This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. ... |
| Substance Abuse Antidote |
|
| Table of Contents Published: 2008/03 Published by: Life Science Analytics |
| This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. ... |
| Substance Abuse Poisoning |
|
| Table of Contents Published: 2008/03 Published by: Life Science Analytics |
| This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. ... |
| Substance Abuse Smoking Cessation |
|
| Table of Contents Published: 2008/03 Published by: Life Science Analytics |
| This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. ... |
| Brands & Strategies: Atypical Antipsychotics |
|
| Table of Contents Published: 2008/02 Published by: Decision Resources, Inc. |
| The atypical antipsychotics market in the United States, Europe, and Japan, valued at an estimated $15.9 billion in sales at ex-manufacturer level in 2007, is expected to expand to over $17.8 billion by 2011, before shrinking to $13.5 billion in 2012. ... |
| CNS Drug Discoveries: what the future holds |
|
| Table of Contents Published: 2006/11 Published by: Espicom Business Intelligence |
| A comprehensive examination of 6 major CNS therapy areas: neurodegenerative disorders, multiple sclerosis, ADHD, depression, sleep disorders and schizophrenia. The report includes unique market share and sales forecasts by product to 2012, as well as deta ... |
|
|
|
View Cart
